SlideShare ist ein Scribd-Unternehmen logo
1 von 27
Chapter 8



             Medication for
            Mental Disorders

© 2011 McGraw-Hill Higher Education. All rights reserved.
Mental Disorders:
                                                 The Medical Model
          Model: symptoms               diagnosis
                 determination of cause treatment cure
                Criticisms of model:
                   Usually the only symptoms of mental disorders are
                          behavioral
                         Behaviors are varied and can have many causes
                Model guides much of current thinking
                  Psychoactive drugs are used to control symptoms of
                          mental illness
                         Researchers seek to identify chemical imbalances
                          associated with specific mental disorders
© 2011 McGraw-Hill Higher Education. All rights reserved.
Classification of Mental
                                             Disorders
          APA Diagnostic and Statistical Manual of
                 Mental Disorders (DSM-IV-TR) provides
                 criteria for classifying mental disorders
                    Includes hundreds of specific diagnostic
                     categories
                    Widely used classification system



© 2011 McGraw-Hill Higher Education. All rights reserved.
Mental Disorders

          Anxiety disorders—characterized by
                 excessive worry, fears, or avoidance
                    Panic disorder
                    Specific phobia
                    Social phobia
                    Obsessive-compulsive disorder
                    Posttraumatic stress disorder
                    Generalized anxiety disorder
© 2011 McGraw-Hill Higher Education. All rights reserved.
Mental Disorders
          Psychosis—a serious mental disorder involving
           loss of contact with reality
          Schizophrenia—chronic
           psychosis characterized by
           delusions, hallucinations,
           disorganized speech and
           behavior, and lack of emotional
           response; causes significant
           interference with social and/or
           occupational functioning

© 2011 McGraw-Hill Higher Education. All rights reserved.
Mental Disorders
          Mood disorders—
                 characterized by depressed
                 or manic symptoms
             Major depression
             Manic episodes
             Bipolar disorder
          Symptoms don’t always fit
           neatly into diagnostic
           categories
© 2011 McGraw-Hill Higher Education. All rights reserved.
Early Treatment of Mental
                                      Disorders
          Syphilitic infection and malaria
                 therapy
                   In the early twentieth century, many
                          psychotic patients were suffering
                          from syphilitic infection of the
                          nervous system (general paresis)
                         Fever associated with malaria was
                          thought to improve the condition
                         Antibiotics were developed that
                          cured syphilis


© 2011 McGraw-Hill Higher Education. All rights reserved.
Early Treatment of Mental
                                      Disorders
          Early drug therapy
                    Narcosis therapy: depressants used to induce sleep
                    Intravenous thiopental sodium (“truth serum”) used
                          during psychotherapy to help patients express
                          themselves
          Insulin-shock therapy
          Electroconvulsive therapy: it was incorrectly
                 believed that inducing convulsions with drugs or
                 electric shocks would cure schizophrenia
                Sedatives used in severely disturbed patients

© 2011 McGraw-Hill Higher Education. All rights reserved.
Antipsychotics: Discovery of
                              Phenothiazines
          Called tranquilizers, neuroleptics, or
           antipsychotics
          Reduce psychotic symptoms without
           causing sedation
          Following introduction of drug therapy,
           restraints and treatments like convulsive
           therapy were reduced or discontinued
           among hospitalized patients

© 2011 McGraw-Hill Higher Education. All rights reserved.
Antipsychotics: Treatment
                                   Considerations
          Treatment with phenothiazines found to be
           more effective than a placebo
          Patients relapse when therapy is
           discontinued
          Two groups of antipsychotics
                    Conventional (introduced before mid-1990s)
                    Atypical (introduced in the past 10 years)

© 2011 McGraw-Hill Higher Education. All rights reserved.
Antipsychotics:
                                         Mechanisms of Action
          Antipsychotics produce
           pseudoparkinsonism, indicating a link to
           dopamine receptors
          Time delay in drug effects indicates that
           the mechanism of action is probably more
           complex
          Atypical antipsychotics block both D2
           dopamine and 5HT2A serotonin receptors
                    Produce less pseudoparkinsonism
© 2011 McGraw-Hill Higher Education. All rights reserved.
Antipsychotics: Side Effects
          Safe in that they are not addictive and are
                 difficult to use to commit suicide
                Side effects
                   Some allergic reactions (jaundice, skin rashes)
                   Photosensitivity (easily sunburned)
                   Agranulocytosis (low white blood cell count)
                   Movement disorders (tremors, muscle rigidity,
                          shuffling walk, masklike face)
                         Tardive dyskinesia



© 2011 McGraw-Hill Higher Education. All rights reserved.
Antipsychotics: Long-term
                                           Effectiveness
          Even patients experiencing success tend to stop taking
                 the drug
                Short-term efficacy exists, but long-term appears to be
                 considerably lower
                No clear evidence that atypical antipsychotics work
                 better than conventional
                When used in children there is a high risk of weight gain
                 and metabolic changes
                Elderly patients with dementia have a significant
                 increase in death risk from cardiovascular and other
                 problems.
© 2011 McGraw-Hill Higher Education. All rights reserved.
Antidepressants: Major Types
          Monoamine oxidase (MAO)
                 inhibitors
                   Examples: phenelzine, tranylcypromine
                Tricyclic antidepressants
                   Examples: amitriptyline, doxepin,
                          nortriptyline
          Selective serotonin reuptake
                 inhibitors (SSRIs)
                   Examples: fluoxetine, sertraline,
                          venlafaxine

© 2011 McGraw-Hill Higher Education. All rights reserved.
Monoamine Oxidase Inhibitors

          Discovered when a drug for tuberculosis
           was found to also elevate mood
          Work by increasing the availability of
           serotonin, norepinephrine, and dopamine
          Limited use due to side effects and toxicity
                    Users must avoid certain foods and drugs to
                          prevent severe side effects


© 2011 McGraw-Hill Higher Education. All rights reserved.
Tricyclic Antidepressants
          Discovered when researchers were working to
                 create a better phenothiazine antipsychotic and
                 found a drug that improved mood
                May work by reducing the uptake (and thereby
                 increasing the availability) of norepinephrine,
                 dopamine, and serotonin
                Not effective in all patients, but they reduce the
                 severity and duration of depressive episodes


© 2011 McGraw-Hill Higher Education. All rights reserved.
Selective Serotonin Reuptake
                              Inhibitors
          SSRIs may work by reducing the uptake (and
                 thereby increasing the availability) of serotonin
                Safer than tricyclic antidepressants, less likely to
                 lead to overdose deaths
                Only a little more effective than placebo
                Strong warning from FDA about an increased
                 risk of suicidal tendencies in children and
                 adolescents


© 2011 McGraw-Hill Higher Education. All rights reserved.
Antidepressants:
                                            Mechanism of Action
          Appear to work by increasing the
           availability of norepinephrine or serotonin
          A lag period before improvement in mood
           is seen
          We don’t yet have the complete picture of
           how antidepressants work



© 2011 McGraw-Hill Higher Education. All rights reserved.
Electroconvulsive Therapy

          Most effective treatment for relieving
           severe depression
          Works very rapidly, more quickly than
           antidepressant drugs
          Best treatment choice in cases with a risk
           of suicide
          Can be used in conjunction with drugs

© 2011 McGraw-Hill Higher Education. All rights reserved.
Mood Stabilizers
          Lithium: Approved for U.S. sale in 1970
                    Early studies found it to be effective in manic
                     patients
                    Acceptance slow in United States
                       Previous history of poisonings
                       Low perception of seriousness of mania
                       U.S. drug approval and sale process
                    Can be safe or toxic; blood levels must be
                     monitored
                    High rate of patient noncompliance
© 2011 McGraw-Hill Higher Education. All rights reserved.
Mood Stabilizers

          Lithium
                    Normalizes mood in bipolar patients,
                          preventing both mania and depressed mood
                          swings
                            Little effect in treating unipolar depression
          Other mood stabilizers are anticonvulsant
                 drugs (valproic acid, carbamazepine,
                 lamotrigine)

© 2011 McGraw-Hill Higher Education. All rights reserved.
Consequences of Drug
                                 Treatment for Mental Illness
          Number of people in mental hospitals
                 declined dramatically following the introduction
                 of drugs that control the symptoms of
                 schizophrenia to a great degree
                Outpatient community mental health
                 programs were set up to treat patients closer to
                 home in a more natural environment at less
                 expense


© 2011 McGraw-Hill Higher Education. All rights reserved.
Number of Patients in Nonfederal
                               Psychiatric Hospitals




                          •In 2008, the number of patients was 68,000, the same as 2004.

                                                            Data source: American Hospital Association
© 2011 McGraw-Hill Higher Education. All rights reserved.
Consequences of Drug
                                  Treatment for Mental Illness
          Changes for psychiatrists
                    Less time spent doing psychotherapy
                    Priority and emphasis on establishing an
                          appropriate drug regimen




© 2011 McGraw-Hill Higher Education. All rights reserved.
Consequences of Drug
                                     Treatment for Mental Illness
          Civil rights issues relating to hospitalization
                    Indefinite commitment to a hospital is unconstitutional
                    Periodic review of a patient’s status helps determine if
                          patient presents a danger to self or others
          Problems
                    Patients may have well-controlled symptoms while on
                          medication in a hospital but may stop taking
                          medication upon release
                         Unmedicated patients, although not overtly
                          dangerous, may still be too ill to care for themselves

© 2011 McGraw-Hill Higher Education. All rights reserved.
Consequences of Drug
                                   Treatment for Mental Illness
          From hospital to jail or the
                 street
                    More mentally ill persons are
                     jailed each year than are admitted
                     to state mental hospitals
                    About one-third of all homeless
                     people have some form of serious
                     mental illness


© 2011 McGraw-Hill Higher Education. All rights reserved.
Chapter 8



              Medication for
             Mental Disorders


© 2011 McGraw-Hill Higher Education. All rights reserved.

Weitere ähnliche Inhalte

Was ist angesagt?

Anxiety disorders in adults 2005
Anxiety disorders in  adults 2005Anxiety disorders in  adults 2005
Anxiety disorders in adults 2005windancer42
 
Antidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+DisorderAntidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+Disorderdhavalshah4424
 
Quick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsQuick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsShah Parind
 
Psychopharmachology dd
Psychopharmachology ddPsychopharmachology dd
Psychopharmachology ddNurEduc
 
Drug Therapy of Depression
Drug Therapy of Depression Drug Therapy of Depression
Drug Therapy of Depression Dr Htet
 
Anxiety Guidelines
Anxiety GuidelinesAnxiety Guidelines
Anxiety GuidelinesAllan F Kane
 
Assessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorderAssessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorderOgechukwu Uzoamaka Mbanu
 
Neurobiology of substance dependence
Neurobiology of substance dependenceNeurobiology of substance dependence
Neurobiology of substance dependenceDr. Sunil Suthar
 
Substance related disorders
Substance related disordersSubstance related disorders
Substance related disordersEric Pazziuagan
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpointAllegra Lange
 
Off-Label Use of Atypical Antipsychotics: An Update
Off-Label Use of Atypical Antipsychotics: An UpdateOff-Label Use of Atypical Antipsychotics: An Update
Off-Label Use of Atypical Antipsychotics: An UpdatePasquale Ariano
 
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsRahul Kunkulol
 

Was ist angesagt? (20)

Anxiety disorders in adults 2005
Anxiety disorders in  adults 2005Anxiety disorders in  adults 2005
Anxiety disorders in adults 2005
 
Antidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+DisorderAntidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+Disorder
 
Anxiety ppt
Anxiety pptAnxiety ppt
Anxiety ppt
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Quick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsQuick Clinical Review of Antipsychotics
Quick Clinical Review of Antipsychotics
 
Pr. Peivand Pirouzi - Challenges in Clinical Research in CNS - Anxiety Disord...
Pr. Peivand Pirouzi - Challenges in Clinical Research in CNS - Anxiety Disord...Pr. Peivand Pirouzi - Challenges in Clinical Research in CNS - Anxiety Disord...
Pr. Peivand Pirouzi - Challenges in Clinical Research in CNS - Anxiety Disord...
 
Psychopharmachology dd
Psychopharmachology ddPsychopharmachology dd
Psychopharmachology dd
 
Pediatric Psychopharmacology
Pediatric PsychopharmacologyPediatric Psychopharmacology
Pediatric Psychopharmacology
 
Drug Therapy of Depression
Drug Therapy of Depression Drug Therapy of Depression
Drug Therapy of Depression
 
Anxiety Guidelines
Anxiety GuidelinesAnxiety Guidelines
Anxiety Guidelines
 
Anxiety: causes, symptoms and treatments
Anxiety: causes, symptoms and treatmentsAnxiety: causes, symptoms and treatments
Anxiety: causes, symptoms and treatments
 
Assessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorderAssessment and management of generalized anxiety disorder
Assessment and management of generalized anxiety disorder
 
Neurobiology of substance dependence
Neurobiology of substance dependenceNeurobiology of substance dependence
Neurobiology of substance dependence
 
Antidepressants & side effects + serotonin syndrome vs
Antidepressants & side effects + serotonin syndrome vsAntidepressants & side effects + serotonin syndrome vs
Antidepressants & side effects + serotonin syndrome vs
 
Substance related disorders
Substance related disordersSubstance related disorders
Substance related disorders
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpoint
 
Off-Label Use of Atypical Antipsychotics: An Update
Off-Label Use of Atypical Antipsychotics: An UpdateOff-Label Use of Atypical Antipsychotics: An Update
Off-Label Use of Atypical Antipsychotics: An Update
 
Therapeutic modalities
Therapeutic modalitiesTherapeutic modalities
Therapeutic modalities
 
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
 
Anxiety disorders
Anxiety disordersAnxiety disorders
Anxiety disorders
 

Ähnlich wie Hart13 ppt ch08

Understanding The Clinical Management Of Pain In Fibromyalgia
Understanding The Clinical Management Of Pain In FibromyalgiaUnderstanding The Clinical Management Of Pain In Fibromyalgia
Understanding The Clinical Management Of Pain In FibromyalgiaMelissa Moore
 
Psychiatric nursing review
Psychiatric nursing  reviewPsychiatric nursing  review
Psychiatric nursing reviewgrey clemente
 
Chapter 13 Psychiatric Medications
Chapter 13   Psychiatric MedicationsChapter 13   Psychiatric Medications
Chapter 13 Psychiatric MedicationsJustin Gatewood
 
Chapter 14 Lecture Disco 4e
Chapter 14 Lecture Disco 4eChapter 14 Lecture Disco 4e
Chapter 14 Lecture Disco 4eprofessorbent
 
Anxiety disorder
Anxiety disorderAnxiety disorder
Anxiety disorderManiz Joshi
 
Mood disorder depression order 7
Mood disorder   depression order 7Mood disorder   depression order 7
Mood disorder depression order 7rfranquiz1
 
Chapter 14 Ppp
Chapter 14 PppChapter 14 Ppp
Chapter 14 Pppcynwong
 
Examining the history, classification, causes and treatment of psychological ...
Examining the history, classification, causes and treatment of psychological ...Examining the history, classification, causes and treatment of psychological ...
Examining the history, classification, causes and treatment of psychological ...Pubrica
 

Ähnlich wie Hart13 ppt ch08 (20)

Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
Psychiatry 5th year, 1st lecture (Dr. Rebwar Ghareeb Hama)
 
CNS part 2
CNS part 2 CNS part 2
CNS part 2
 
Understanding The Clinical Management Of Pain In Fibromyalgia
Understanding The Clinical Management Of Pain In FibromyalgiaUnderstanding The Clinical Management Of Pain In Fibromyalgia
Understanding The Clinical Management Of Pain In Fibromyalgia
 
Antisychotic Drugs
Antisychotic DrugsAntisychotic Drugs
Antisychotic Drugs
 
Psychiatric nursing review
Psychiatric nursing  reviewPsychiatric nursing  review
Psychiatric nursing review
 
Chapter 13 Psychiatric Medications
Chapter 13   Psychiatric MedicationsChapter 13   Psychiatric Medications
Chapter 13 Psychiatric Medications
 
B.slides
B.slidesB.slides
B.slides
 
Bipolar Disorder
Bipolar DisorderBipolar Disorder
Bipolar Disorder
 
Chapter 14 Lecture Disco 4e
Chapter 14 Lecture Disco 4eChapter 14 Lecture Disco 4e
Chapter 14 Lecture Disco 4e
 
Psychiatric_Disorder.pptx
Psychiatric_Disorder.pptxPsychiatric_Disorder.pptx
Psychiatric_Disorder.pptx
 
antipsychoticdrugs.pptx
antipsychoticdrugs.pptxantipsychoticdrugs.pptx
antipsychoticdrugs.pptx
 
Bipolar disorder
Bipolar disorderBipolar disorder
Bipolar disorder
 
Antidepressant
AntidepressantAntidepressant
Antidepressant
 
Anxiety disorder
Anxiety disorderAnxiety disorder
Anxiety disorder
 
Mood disorder depression order 7
Mood disorder   depression order 7Mood disorder   depression order 7
Mood disorder depression order 7
 
Tranquilisers
TranquilisersTranquilisers
Tranquilisers
 
Chapter 14 Ppp
Chapter 14 PppChapter 14 Ppp
Chapter 14 Ppp
 
Sleep apnea
Sleep apneaSleep apnea
Sleep apnea
 
Examining the history, classification, causes and treatment of psychological ...
Examining the history, classification, causes and treatment of psychological ...Examining the history, classification, causes and treatment of psychological ...
Examining the history, classification, causes and treatment of psychological ...
 
ANTIPSYCHOTIC
ANTIPSYCHOTICANTIPSYCHOTIC
ANTIPSYCHOTIC
 

Hart13 ppt ch08

  • 1. Chapter 8 Medication for Mental Disorders © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 2. Mental Disorders: The Medical Model  Model: symptoms diagnosis determination of cause treatment cure  Criticisms of model:  Usually the only symptoms of mental disorders are behavioral  Behaviors are varied and can have many causes  Model guides much of current thinking  Psychoactive drugs are used to control symptoms of mental illness  Researchers seek to identify chemical imbalances associated with specific mental disorders © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 3. Classification of Mental Disorders  APA Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) provides criteria for classifying mental disorders  Includes hundreds of specific diagnostic categories  Widely used classification system © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 4. Mental Disorders  Anxiety disorders—characterized by excessive worry, fears, or avoidance  Panic disorder  Specific phobia  Social phobia  Obsessive-compulsive disorder  Posttraumatic stress disorder  Generalized anxiety disorder © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 5. Mental Disorders  Psychosis—a serious mental disorder involving loss of contact with reality  Schizophrenia—chronic psychosis characterized by delusions, hallucinations, disorganized speech and behavior, and lack of emotional response; causes significant interference with social and/or occupational functioning © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 6. Mental Disorders  Mood disorders— characterized by depressed or manic symptoms  Major depression  Manic episodes  Bipolar disorder  Symptoms don’t always fit neatly into diagnostic categories © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 7. Early Treatment of Mental Disorders  Syphilitic infection and malaria therapy  In the early twentieth century, many psychotic patients were suffering from syphilitic infection of the nervous system (general paresis)  Fever associated with malaria was thought to improve the condition  Antibiotics were developed that cured syphilis © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 8. Early Treatment of Mental Disorders  Early drug therapy  Narcosis therapy: depressants used to induce sleep  Intravenous thiopental sodium (“truth serum”) used during psychotherapy to help patients express themselves  Insulin-shock therapy  Electroconvulsive therapy: it was incorrectly believed that inducing convulsions with drugs or electric shocks would cure schizophrenia  Sedatives used in severely disturbed patients © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 9. Antipsychotics: Discovery of Phenothiazines  Called tranquilizers, neuroleptics, or antipsychotics  Reduce psychotic symptoms without causing sedation  Following introduction of drug therapy, restraints and treatments like convulsive therapy were reduced or discontinued among hospitalized patients © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 10. Antipsychotics: Treatment Considerations  Treatment with phenothiazines found to be more effective than a placebo  Patients relapse when therapy is discontinued  Two groups of antipsychotics  Conventional (introduced before mid-1990s)  Atypical (introduced in the past 10 years) © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 11. Antipsychotics: Mechanisms of Action  Antipsychotics produce pseudoparkinsonism, indicating a link to dopamine receptors  Time delay in drug effects indicates that the mechanism of action is probably more complex  Atypical antipsychotics block both D2 dopamine and 5HT2A serotonin receptors  Produce less pseudoparkinsonism © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 12. Antipsychotics: Side Effects  Safe in that they are not addictive and are difficult to use to commit suicide  Side effects  Some allergic reactions (jaundice, skin rashes)  Photosensitivity (easily sunburned)  Agranulocytosis (low white blood cell count)  Movement disorders (tremors, muscle rigidity, shuffling walk, masklike face)  Tardive dyskinesia © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 13. Antipsychotics: Long-term Effectiveness  Even patients experiencing success tend to stop taking the drug  Short-term efficacy exists, but long-term appears to be considerably lower  No clear evidence that atypical antipsychotics work better than conventional  When used in children there is a high risk of weight gain and metabolic changes  Elderly patients with dementia have a significant increase in death risk from cardiovascular and other problems. © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 14. Antidepressants: Major Types  Monoamine oxidase (MAO) inhibitors  Examples: phenelzine, tranylcypromine  Tricyclic antidepressants  Examples: amitriptyline, doxepin, nortriptyline  Selective serotonin reuptake inhibitors (SSRIs)  Examples: fluoxetine, sertraline, venlafaxine © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 15. Monoamine Oxidase Inhibitors  Discovered when a drug for tuberculosis was found to also elevate mood  Work by increasing the availability of serotonin, norepinephrine, and dopamine  Limited use due to side effects and toxicity  Users must avoid certain foods and drugs to prevent severe side effects © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 16. Tricyclic Antidepressants  Discovered when researchers were working to create a better phenothiazine antipsychotic and found a drug that improved mood  May work by reducing the uptake (and thereby increasing the availability) of norepinephrine, dopamine, and serotonin  Not effective in all patients, but they reduce the severity and duration of depressive episodes © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 17. Selective Serotonin Reuptake Inhibitors  SSRIs may work by reducing the uptake (and thereby increasing the availability) of serotonin  Safer than tricyclic antidepressants, less likely to lead to overdose deaths  Only a little more effective than placebo  Strong warning from FDA about an increased risk of suicidal tendencies in children and adolescents © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 18. Antidepressants: Mechanism of Action  Appear to work by increasing the availability of norepinephrine or serotonin  A lag period before improvement in mood is seen  We don’t yet have the complete picture of how antidepressants work © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 19. Electroconvulsive Therapy  Most effective treatment for relieving severe depression  Works very rapidly, more quickly than antidepressant drugs  Best treatment choice in cases with a risk of suicide  Can be used in conjunction with drugs © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 20. Mood Stabilizers  Lithium: Approved for U.S. sale in 1970  Early studies found it to be effective in manic patients  Acceptance slow in United States  Previous history of poisonings  Low perception of seriousness of mania  U.S. drug approval and sale process  Can be safe or toxic; blood levels must be monitored  High rate of patient noncompliance © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 21. Mood Stabilizers  Lithium  Normalizes mood in bipolar patients, preventing both mania and depressed mood swings  Little effect in treating unipolar depression  Other mood stabilizers are anticonvulsant drugs (valproic acid, carbamazepine, lamotrigine) © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 22. Consequences of Drug Treatment for Mental Illness  Number of people in mental hospitals declined dramatically following the introduction of drugs that control the symptoms of schizophrenia to a great degree  Outpatient community mental health programs were set up to treat patients closer to home in a more natural environment at less expense © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 23. Number of Patients in Nonfederal Psychiatric Hospitals •In 2008, the number of patients was 68,000, the same as 2004. Data source: American Hospital Association © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 24. Consequences of Drug Treatment for Mental Illness  Changes for psychiatrists  Less time spent doing psychotherapy  Priority and emphasis on establishing an appropriate drug regimen © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 25. Consequences of Drug Treatment for Mental Illness  Civil rights issues relating to hospitalization  Indefinite commitment to a hospital is unconstitutional  Periodic review of a patient’s status helps determine if patient presents a danger to self or others  Problems  Patients may have well-controlled symptoms while on medication in a hospital but may stop taking medication upon release  Unmedicated patients, although not overtly dangerous, may still be too ill to care for themselves © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 26. Consequences of Drug Treatment for Mental Illness  From hospital to jail or the street  More mentally ill persons are jailed each year than are admitted to state mental hospitals  About one-third of all homeless people have some form of serious mental illness © 2011 McGraw-Hill Higher Education. All rights reserved.
  • 27. Chapter 8 Medication for Mental Disorders © 2011 McGraw-Hill Higher Education. All rights reserved.

Hinweis der Redaktion

  1. Image sources: Comstock Images/PictureQuest (Image Ch08_01MedicineCabinet); Mel Curtis/Getty Images (Image Ch08_07Depression)
  2. Image source: Digital Vision / Getty Image (Image Ch08_02MentalIllness)
  3. Image source: Royalty-Free/Corbis (Image Ch08_03Anxiety)
  4. Image source: The McGraw-Hill Companies, Inc./Lars A. Niki, photographer (Image Ch08_04Schizophrenia)
  5. Image source: Royalty-Free/Corbis (Image Ch08_05Depression)
  6. Image source: Library of Congress Prints and Photographs Division (Image Ch08_06SyphilisMental)
  7. Image source: Royalty-Free/Corbis (Image Ch08_11PrescriptionPills)
  8. Figure 8.1 from text
  9. Image source: Royalty-Free/Corbis (Image Ch08_08Psychiatrist) Image source: Tracy Montana/PhotoLink/Getty Image (Image Ch08_12PrescriptionPills)
  10. Image source (prison): BrandX Pictures (Image Ch08_09Prison) Image source (homeless): The McGraw-Hill Companies, Inc./Christopher Kerrigan, photographer (Image Ch08_10Homeless)
  11. Image sources: Comstock Images/PictureQuest (Image Ch08_01MedicineCabinet); Mel Curtis/Getty Images (Image Ch08_07Depression)